Genor Biopharma Holdings Ltd. held its annual general meeting on June 26, 2025. During the meeting, all proposed resolutions were approved. These included the retirement of Dr. Lyu Dong as a non-executive director and a change in the composition of the board committee, with Mr. Chen Wen appointed as the chairman of the Nomination Committee, and Mr. Fung Edwin and Ms. Cui Bai as members.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.